Most equity fund money is concentrated in a few prominent indices, including those which target the Biotech/Life Sciences arena. Yet not all Biotech indices are alike, and large compositional differences can lead to significantly different results. In this paper, we analyze their differences and look at which index leads the pack for the last 3-, 5- and 10-year periods.